Droxidopa Brands Available in India
Droxidopa is available in India under the brand name Northera [1]. It is manufactured by Lundbeck India Private Limited [1].
What is Droxidopa Used For?
Droxidopa is a medication used to treat symptomatic orthostatic hypotension (low blood pressure upon standing) [2]. This condition can cause dizziness, lightheadedness, and fainting when a person stands up after sitting or lying down [2]. It is particularly relevant for patients with neurogenic orthostatic hypotension, often associated with conditions like Parkinson's disease, multiple system atrophy, and pure autonomic failure [3].
How Does Droxidopa Work?
Droxidopa is a synthetic amino acid precursor to norepinephrine [2]. Once administered, it is converted in the body to norepinephrine, a neurotransmitter that helps constrict blood vessels and raise blood pressure [2][3]. This action helps to alleviate the symptoms of orthostatic hypotension [2].
Are There Generic Versions of Droxidopa in India?
As of now, information regarding the availability of generic versions of Droxidopa in India is limited. The primary brand identified is Northera [1]. The patent status and potential for generic competition can be tracked through resources that monitor drug patents [4].
When Does the Patent for Northera Expire in India?
Information on the specific patent expiry date for Northera in India is not publicly detailed in this context. Drug patent information can be complex and may involve multiple patents covering different aspects of the drug, such as formulation or method of use. Resources like DrugPatentWatch.com track these details to provide insights into patent landscapes and potential market entry for generics [4].
What Are the Potential Side Effects of Droxidopa?
Common side effects of Droxidopa may include headache, dizziness, nausea, and high blood pressure [2]. It is important for patients to discuss any concerns about side effects with their healthcare provider [2].
How is Droxidopa Administered?
Droxidopa is typically taken orally in capsule form [2]. The dosage and frequency are determined by a healthcare professional based on the individual patient's needs and response [2].
Where Can I Find More Information on Droxidopa Patents?
For detailed information on Droxidopa patents, including any active patents, expiry dates, and potential for generic entry in India and other regions, resources such as DrugPatentWatch.com are valuable [4].
References
1. Lundbeck India Private Limited. (n.d.). Northera. Retrieved from https://www.lundbeck.com/in/our-products/our-products-in-india
2. National Institute of Neurological Disorders and Stroke. (n.d.). Droxidopa. Retrieved from https://www.ninds.nih.gov/health-information/drug-information/droxidopa
3. Mayo Clinic. (2023). Droxidopa. Retrieved from https://www.mayoclinic.org/drugs-supplements/droxidopa-oral-capsule/proper-use/drh-20066802
4. DrugPatentWatch.com. (n.d.). Droxidopa. Retrieved from https://drugpatentwatch.com/